Miyagaki M, Zong Y, Yang M, Zhang J, Zou Y, Ohno-Matsui K
Pathogens. 2024; 13(10).
PMID: 39452769
PMC: 11509995.
DOI: 10.3390/pathogens13100898.
Zhang J, Kamoi K, Zong Y, Yang M, Zou Y, Miyagaki M
Viruses. 2024; 16(9).
PMID: 39339903
PMC: 11437412.
DOI: 10.3390/v16091427.
Chen Z, Cheng S, Chen X, Zhang Z, Du Y
Front Immunol. 2024; 15:1403025.
PMID: 38799473
PMC: 11116678.
DOI: 10.3389/fimmu.2024.1403025.
Amaral D, Lane M, Cassins Aguiar E, Marques G, Cavassani L, Rodrigues M
Int J Retina Vitreous. 2024; 10(1):23.
PMID: 38424638
PMC: 10903043.
DOI: 10.1186/s40942-024-00540-w.
Javed S, Abbas G, Shah S, Rasul A, Irfan M, Saleem A
Heliyon. 2023; 9(9):e19877.
PMID: 37809498
PMC: 10559273.
DOI: 10.1016/j.heliyon.2023.e19877.
Retinitis Pigmentosa Masquerades: Case Series and Review of the Literature.
Thenappan A, Nanda A, Lee C, Lee S
J Clin Med. 2023; 12(17).
PMID: 37685687
PMC: 10489117.
DOI: 10.3390/jcm12175620.
Clinical outcomes of intravitreal treatment for ocular toxoplasmosis: systematic review and meta-analysis.
Amaral de Melo L, Paiva M, Fernandes-Cunha G, Silva-Cunha A, Mol M, Fialho S
Rev Soc Bras Med Trop. 2023; 56:e05522022.
PMID: 37222350
PMC: 10204153.
DOI: 10.1590/0037-8682-0552-2022.
Prenatal ultrasound findings of X-linked congenital cataracts: case report and description of a novel variant.
Zheng Y, Li L, Wang L, Zhang C
Am J Transl Res. 2023; 14(12):9066-9071.
PMID: 36628231
PMC: 9827286.
Optic perineuritis as an initial presentation of ocular toxoplasmosis: a case report.
Chung S, Kim C, Lim J, Chung Y
Int J Ophthalmol. 2022; 15(12):2043-2046.
PMID: 36536968
PMC: 9729083.
DOI: 10.18240/ijo.2022.12.25.
Long-Term Outcomes in Children with Congenital Toxoplasmosis-A Systematic Review.
Garweg J, Kieffer F, Mandelbrot L, Peyron F, Wallon M
Pathogens. 2022; 11(10).
PMID: 36297244
PMC: 9610672.
DOI: 10.3390/pathogens11101187.
Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview.
Felin M, Wang K, Moreira A, Grose A, Leahy K, Zhou Y
Curr Pediatr Rep. 2022; 10(3):57-92.
PMID: 36034212
PMC: 9395898.
DOI: 10.1007/s40124-022-00269-w.
Building Programs to Eradicate Toxoplasmosis Part IV: Understanding and Development of Public Health Strategies and Advances "Take a Village".
Felin M, Wang K, Moreira A, Grose A, Leahy K, Zhou Y
Curr Pediatr Rep. 2022; 10(3):125-154.
PMID: 35991908
PMC: 9379243.
DOI: 10.1007/s40124-022-00268-x.
The Role of Corticosteroids in Treating Acute Ocular Toxoplasmosis in an Immunocompetent Patient: A Case Report.
Lin H, Annabelle Lee W
Front Med (Lausanne). 2022; 9:843050.
PMID: 35847774
PMC: 9276926.
DOI: 10.3389/fmed.2022.843050.
Treatment of a full-thickness macular hole and retinal detachment secondary to toxoplasma chorioretinitis that developed shortly after COVID-19: A case report.
Erol M, Bozdogan Y, Suren E, Gedik B
J Fr Ophtalmol. 2022; 45(4):446-451.
PMID: 35034856
PMC: 8733215.
DOI: 10.1016/j.jfo.2021.12.004.
Comprehensive Overview of -Induced and Associated Diseases.
Daher D, Shaghlil A, Sobh E, Hamie M, Hassan M, Moumneh M
Pathogens. 2021; 10(11).
PMID: 34832507
PMC: 8625914.
DOI: 10.3390/pathogens10111351.
Neuroretinitis and Juxtapapillary Retinochoroiditis as Atypical Presentations of Ocular Toxoplasmosis.
Kabedi N, Mwanza J
Int Med Case Rep J. 2021; 14:657-661.
PMID: 34588823
PMC: 8473713.
DOI: 10.2147/IMCRJ.S332147.
Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches.
Kalogeropoulos D, Sakkas H, Mohammed B, Vartholomatos G, Malamos K, Sreekantam S
Int Ophthalmol. 2021; 42(1):295-321.
PMID: 34370174
PMC: 8351587.
DOI: 10.1007/s10792-021-01994-9.
A Review on the Present Advances on Studies of Toxoplasmosis in Eastern Africa.
Mokua Mose J, Kagira J, Kamau D, Maina N, Ngotho M, Karanja S
Biomed Res Int. 2020; 2020:7135268.
PMID: 32724808
PMC: 7364236.
DOI: 10.1155/2020/7135268.
Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites.
McPhillie M, Zhou Y, Hickman M, Gordon J, Weber C, Li Q
Front Cell Infect Microbiol. 2020; 10:203.
PMID: 32626661
PMC: 7311950.
DOI: 10.3389/fcimb.2020.00203.
Effects of Congenital Ocular Toxoplasmosis on Peripheral Retinal Vascular Development in Premature Infants at Low Risk for Retinopathy of Prematurity.
Hasanreisoglu M, Ozdek S, Gulpinar Ikiz G, Aktas Z, Atalay T
Turk J Ophthalmol. 2019; 49(4):230-234.
PMID: 31486615
PMC: 6761382.
DOI: 10.4274/tjo.galenos.2019.74484.